On the contrary, the presence of mutations in splicing factor genes (e.g, SRSF2, U2AF1) in addition to EZH2 and STAG2 is more indicative of high risk vs. low risk MDS. The gene discussed is U2AF1; the disease is myelodysplastic syndrome.